About this episode

The episode discusses the transition of urologists into leadership roles in the life sciences industry.

What happens when urologists look beyond the clinic and take on leadership in the life sciences industry? In this episode of BackTable Urology, host Dr. Raj Pruthi talks with Dr. Kelly Parsons and Dr. Pat Keegan about their journeys from academic urology to executive roles in biotech and pharma. They discuss what motivated their transitions, how physician expertise adds value in industry, and the realities of life outside of traditional clinical practice. --- Get the BackTable apphttps://www.backtable.com/app --- Timestamps 00:00 - Introduction05:36 - Choosing a Non-Clinical Path11:07 - Reactions from Mentors and Peers14:31 - What Feels Most Fulfilling18:31 - A Typical Week in Biotech26:04 - Working with Investors31:21 - Additional Degrees and MBA Debate35:31 - Is it Risky to Leave Clinical Practice?44:13 - Networking and Next Steps47:59 - Wrap Up --- More about this episode The conversation explores the day-to-day work of industry leaders, the impact of advanced degrees like MBAs, and the importance of networking for physicians considering a nonclinical path. Drs. Parsons and Keegan reflect on the challenges and rewards of leaving clinical medicine, the support and reactions…

People in this episode

Host: Dr. Raj Pruthi

Guests: Dr. Kelly Parsons, Dr. Pat Keegan

Topics covered

• career diversification
• urology
• biotech
• pharma
• non-clinical paths
• leadership
• networking

Keywords

• urologists
• biotech
• pharma
• career transition
• non-clinical
• mentorship
• networking

Mentioned in this episode

Organizations: BackTable

More episodes of BackTable Urology

• Ep. 318 Exploring Neuromodulation: Sacral vs Tibial Approaches with Dr. Ken Peters and Dr. Tracey Wilson · July 21, 2026 · 1h 0m
• Ep. 317 Focal Therapy in Prostate Cancer Treatment with Dr. George R. Schade · July 16, 2026 · 48 min
• Ep. 316 Bladder Cancer in the Community: Meeting Patients Where They Are with Dr. Adam J. Gadzinski · July 14, 2026 · 49 min
• Ep. 315 Private Equity's Impact on Urology Practices with Dr. Benjamin Lowentritt · July 10, 2026 · 49 min
• Ep. 314 Exploring PARP Inhibitor Combinations in Prostate Cancer with Dr. Rana McKay and Dr. Emmanuel Antonarakis · July 7, 2026 · 52 min
• Ep. 313 Approaches to Pelvic Lymph Node Dissection in Contemporary Prostate Cancer Surgery with Dr. Kristen Greene · June 30, 2026 · 36 min

Explore listener stats, chart rankings, contacts and more on the BackTable Urology podcast page.